Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 4,756 shares at $234.17 ($1.1M) on 2020-09-03, disclosed to the SEC on 2020-09-08.
Open-market sale of $1.1M BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $232.25 | 1,000 | $232K | 20.9% |
| 2 | $232.94 | 1,411 | $329K | 29.6% |
| 3 | $232.94 | 1,411 | $329K | 29.6% |
| 4 | $234.17 | 500 | $117K | 10.6% |
| 5 | $235.21 | 217 | $51K | 4.6% |
| 6 | $235.21 | 217 |
| $51K |
| 4.6% |
| Total | $233.13 avg | 4,756 | $1.1M | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |